ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins.

Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
Hanna RuhanenVesa M Olkkonen

Abstract

Loss-of-function (LOF) mutations in ANGPTL3, an inhibitor of lipoprotein lipase (LPL), cause a drastic reduction of serum lipoproteins and protect against the development of atherosclerotic cardiovascular disease. Therefore, ANGPTL3 is a promising therapy target. We characterized the impacts of ANGPTL3 depletion on the immortalized human hepatocyte (IHH) transcriptome, lipidome and human plasma lipoprotein lipidome. The transcriptome of ANGPTL3 knock-down (KD) cells showed altered expression of several pathways related to lipid metabolism. Accordingly, ANGPTL3 depleted IHH displayed changes in cellular overall fatty acid (FA) composition and in the lipid species composition of several lipid classes, characterized by abundant n-6 and n-3 polyunsaturated FAs (PUFAs). This PUFA increase coincided with an elevation of lipid mediators, among which there were species relevant for resolution of inflammation, protection from lipotoxic and hypoxia-induced ER stress, hepatic steatosis and insulin resistance or for the recovery from cardiovascular events. Cholesterol esters were markedly reduced in ANGPTL3 KD IHH, coinciding with suppression of the SOAT1 mRNA and protein. ANGPTL3 LOF caused alterations in plasma lipoprotein FA and lipid s...Continue Reading

References

Jan 1, 1986·Methods in Enzymology·L R McLeanR L Jackson
Jan 1, 1993·Biochimie·H van den BoschR B Schutgens
Oct 18, 1996·Biochimica Et Biophysica Acta·J HuuskonenC Ehnholm
Jul 5, 2002·The Journal of Biological Chemistry·Tetsuya ShimizugawaHidehiko Furukawa
Feb 5, 2003·Biochemical and Biophysical Research Communications·Mitsuru ShimamuraIichiro Shimomura
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Oct 7, 2004·Journal of Lipid Research·Papasani V SubbaiahMichael H Davidson
May 10, 2006·Journal of Lipid Research·Nathalie GriffonDaniel J Rader
Nov 18, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Mitsuru ShimamuraIichiro Shimomura
Dec 15, 2006·Analytical Chemistry·Perttu HaimiPentti Somerharju
Oct 15, 2010·The New England Journal of Medicine·Kiran MusunuruSekar Kathiresan
Apr 22, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Emanuela Ricciotti, Garret A FitzGerald
Mar 30, 2012·Omics : a Journal of Integrative Biology·Guangchuang YuQing-Yu He
Jun 5, 2012·The Journal of Clinical Endocrinology and Metabolism·Ilenia MinicocciMarcello Arca
May 11, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Marius R RobciucMatti Jauhiainen
Oct 15, 2013·Biochimica Et Biophysica Acta·Kenneth D'Souza, Richard M Epand
Aug 15, 2014·The Journal of Nutrition·Ariful IslamYuji Owada
Aug 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Paul C NorrisEdward A Dennis
Mar 18, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Daisuke AkagiMichael S Conte
May 9, 2015·Journal of Lipid Research·Yan WangHelen H Hobbs
May 13, 2015·Journal of Lipid Research·Viktoria GusarovaJesper Gromada
Jul 24, 2015·The Journal of Clinical Endocrinology and Metabolism·P A Nidhina HaridasHannele Yki-Järvinen
Apr 5, 2016·Journal of Lipid Research·Ilenia MinicocciMarcello Arca
Apr 29, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tarec K ElajamiFrancine K Welty
Jul 6, 2016·Biochimica Et Biophysica Acta·Krishna Chaithanya BatchuPentti Somerharju
Nov 2, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Romain A ColasCharles N Serhan
Apr 8, 2017·Journal of the American College of Cardiology·Nathan O StitzielUNKNOWN PROMIS and Myocardial Infarction Genetics Consortium Investigators

❮ Previous
Next ❯

Citations

Nov 2, 2021·Frontiers in Veterinary Science·Zhiwei KongZhiliang Tan
Sep 29, 2021·Current Opinion in Lipidology·Sander Kersten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Related Papers

Journal of the American College of Cardiology
Nathan O StitzielPROMIS and Myocardial Infarction Genetics Consortium Investigators
Biochemical and Biophysical Research Communications
Kouichi InukaiShigehiro Katayama
Biochemical and Biophysical Research Communications
Mitsuru ShimamuraIichiro Shimomura
© 2021 Meta ULC. All rights reserved